Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00112827
Status:
COMPLETED
Last Update Posted:
2021-03-01
First Post:
2005-06-02
Brief Title:
Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I Stage II or Stage III Multiple Myeloma
Sponsor:
City of Hope Medical Center
Organization:
City of Hope Medical Center
Organization Data
Organization:
City of Hope Medical Center
Class:
OTHER
Study ID:
COH 04064
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
City of Hope Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None